The BD Neopak™ Glass Prefillable Syringe platform with tailorable medication delivery solution can help support the development of your biologic drug. Getting your drug to market with a solution focused on patient safety and usability

BD Hypak TM Glass Prefillable Syringe (PFS) for Anticoagulant is a tool for anticoagulant combination product developers. BD provides customizable prefillable syringe systems treating chronic diseases. Our prefillable vaccine syringes provide multiple routes of administration options while helping enhance vaccination outcomes.¹.

BD Effivax™ Glass Prefillable Syringe is a single use Sterile Clean and Ready to Fill syringe (BD SCF™), designed, when combined with an appropriate needle and injection technique, for manual intramuscular or subcutaneous injections of pharmaceutical drugs. 1 Featuring a new vaccine prefillable syringe (PFS) barrel, and a step forward in ...

Providing expertise in prefillable syringe (PFS) technology you can trust Biologics requiring high viscosity and high volume formulations continue to grow significantly in the market 1. The BD Neopak™ Glass Prefillable Syringe platform has been …

BD offers an integrated PFS system approach, backed by a comprehensive portfolio of syringes, stoppers and other drug delivery solutions. Look closer at how we can help you advance biologics at each step… with the BD Neopak™ Glass Prefillable Syringe Platform and the BD SCF™ PremiumCoat® Plunger Stopper.

Since the first BD Hypak™ glass prefillable syringe (PFS) was introduced in 1954, BD has continued to innovate, developing ever more efficient manufacturing processes, novel technologies, and improved patient experiences.

Innovative RFID-based solution for prefillable syringes (PFS) aims to enhance efficiency and improve traceability during the fill & finish process and product distribution.

BD NeopakTM XSiTM Glass Prefillable Syringes have been designed for improved integrity of the lubricant layer reducing subvisible particle level of biologic formulation in PFSs, particularly for drugs that may be very sensitive to silicone oil.1

BD offers an extensive portfolio of patient centric, self-administered drug delivery solutions including disposable autoinjectors, disposable variable dose pen injectors, and wearable injectors designed to deliver a wide range of volumes and viscosities …

FRANKLIN LAKES, N.J., Sept. 13, 2022 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics ...